Lothar Steidler
Chief Tech/Sci/R&D Officer at Intrexon ActoBiotics NV
Profile
Lothar Steidler is currently working as the Vice President-Technology at Intrexon ActoBiotics NV since 2013.
Previously, he held positions as Principal at Ghent University, University College Cork, and Vlaams Instituut voor Biotechnologie - Flanders Institute.
He obtained his doctorate degree from Ghent University.
Lothar Steidler active positions
| Companies | Position | Start |
|---|---|---|
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Chief Tech/Sci/R&D Officer | 2013-04-22 |
Former positions of Lothar Steidler
| Companies | Position | End |
|---|---|---|
| University College Cork | Corporate Officer/Principal | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
| Ghent University | Corporate Officer/Principal | - |
Training of Lothar Steidler
| Ghent University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
- Stock Market
- Insiders
- Lothar Steidler